Courses List

0
No products in the cart.
← Literature Database

Pacemakers, implantable cardioverter/defibrillators, and extracorporeal shockwave lithotripsy: evidence-based guidelines for the modern era.

Editor's Choice

Michael A Platonov, Anne M Gillis, Katherine M Kavanagh

Journal of endourology · 2008 · Vol. 22 · Issue 2 · 243-7

PMID: 18294028 DOI: 10.1089/end.2007.0021

Academy Summary

Platonov, Gillis and Kavanagh reviewed the evidence concerning shock wave lithotripsy in patients with permanent pacemakers and implantable cardioverter-defibrillators (ICDs) and proposed practical management recommendations for modern SWL.

Historically, implanted cardiac devices were considered vulnerable to both the mechanical effects of shock waves and electromagnetic interference generated during lithotripsy.

Potential concerns included:

  • Shock-wave oversensing
  • Inappropriate inhibition of pacemaker output
  • Inappropriate antitachycardia pacing
  • Inappropriate ICD shock delivery
  • Rate-response activation
  • Device malfunction or physical damage

However, both technologies had evolved considerably by the time of this review. Modern lithotripters delivered more focused energy with less far-field exposure, while newer pacemakers and ICDs incorporated improved shielding, filtering and electromagnetic-interference discrimination. (pubmed.ncbi.nlm.nih.gov)

The authors found that manufacturer recommendations differed substantially and that practice varied between lithotripsy centres because there was no uniform national standard.

They therefore proposed a practical protocol based on the available experimental evidence, clinical reports, manufacturer recommendations and contemporary device technology.

Their recommended approach included:

  • Continuous cardiac monitoring during SWL
  • Immediate availability of pacemaker/ICD interrogation and programming equipment
  • Availability of personnel capable of device programming
  • Immediate access to resuscitation equipment
  • Stopping SWL if a clinically significant arrhythmia develops
  • Device interrogation if pacing failure, unexplained tachycardia or device malfunction is suspected
  • Temporary asynchronous pacing if SWL suppresses pacemaker output
  • Consideration of ICD tachyarrhythmia-therapy deactivation when clinically appropriate
  • Post-treatment device interrogation when there is concern regarding device function (go.gale.com)

The review therefore helped consolidate the transition from:

“Pacemaker or ICD = contraindication to SWL”

toward:

“Pacemaker or ICD = SWL may be performed with device-specific precautions.”

This principle remains reflected in current EAU guidance. Patients with pacemakers may undergo SWL when appropriate technical precautions are taken, while patients with ICDs require additional consideration regarding device firing mode. The EAU also notes that temporary ICD reprogramming may not always be required with newer-generation lithotripters. (uroweb.org)

Unlock the Academy Interpretation for Free

Create a free Lithotripsy Academy account or log in to access the complete Academy interpretation, including Key Findings, Clinical Takeaway, Limitations, and Expert Commentary

Subscribe to View Details Already a member? Log in

Continue Learning

Explore related clinical guidance and structured education.

Comments & Discussion0 comments

Discuss the publication's evidence, limitations and practical relevance. Please do not include identifiable patient information or individual medical advice.

No comments yet. Start the discussion.